Business acquisition

Strides Acquires Sandoz's Africa Generics Portfolio

Analysis based on 9 articles · First reported Mar 17, 2026 · Last updated Mar 19, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The acquisition by Strides Pharma Science is expected to positively impact the pharmaceutical market in Sub-Saharan Africa by increasing competition and potentially improving access to affordable medicines. For Strides Pharma Science, this deal is expected to be EPS-accretive and will significantly boost its market position.

Pharmaceuticals

Event Summary

Strides Pharma Science, through its subsidiary Strides Pharma Science===Strides Pharma International AG, has entered into an agreement with Sandoz AG to acquire and in-license a portfolio of branded generic products across Sub-Saharan Africa. The deal, valued at USD 12 million, will expand Strides Pharma Science's footprint in key markets including Western Sahara, Ghana, Nigeria, and Kenya, positioning it among the top pharmaceutical players in the region. The portfolio includes products in anti-infective, cardiovascular, and dermatology segments. The transaction is expected to close by Q2 FY27, subject to regulatory approvals, and is anticipated to be EPS-accretive for Strides Pharma Science.

Key Actions

100 Strides Pharma Science===Strides Pharma International AG acquired and in-licensed a portfolio of branded generic products Sandoz

90 Strides Pharma Science expanded its presence and market share

80 Sandoz divested a portfolio of branded generic products Strides Pharma Science===Strides Pharma International AG

Entities Involved

stock

Strides Pharma Science

Strides Pharma Science is acquiring a portfolio of branded generic products from Sandoz AG, significantly expanding its presence and market share in Sub-Saharan Africa. This transaction is expected to be EPS-accretive and will position Strides Pharma Science among the top pharmaceutical companies in the region.

Importance 100 Sentiment 70

subs

Strides Pharma Science===Strides Pharma International AG

Strides Pharma Science===Strides Pharma International AG, a subsidiary of Strides Pharma Science, is the direct entity entering into the definitive agreements with Sandoz AG for the acquisition and in-licensing of the product portfolio.

Importance 90 Sentiment 70

stock

Sandoz

Sandoz AG is divesting a portfolio of branded generic products in Sub-Saharan Africa to Strides Pharma Science as part of its portfolio optimization strategy, allowing it to sharpen its focus on core global generics and biosimilars operations.

Importance 80 Sentiment 20

cnt

Ghana

Ghana is one of the key markets in Sub-Saharan Africa where Strides Pharma Science will expand its footprint through the acquisition of Sandoz AG's product portfolio.

Importance 30 Sentiment 0

cnt

Nigeria

Nigeria is one of the key markets in Sub-Saharan Africa where Strides Pharma Science will expand its footprint through the acquisition of Sandoz AG's product portfolio.

Importance 30 Sentiment 0

cnt

Kenya

Kenya is one of the key markets in Sub-Saharan Africa where Strides Pharma Science will expand its footprint through the acquisition of Sandoz AG's product portfolio.

Importance 30 Sentiment 0

cnt

Western Sahara

Western Sahara is one of the key markets in Sub-Saharan Africa where Strides Pharma Science will expand its footprint through the acquisition of Sandoz AG's product portfolio.

Importance 30 Sentiment 0

+ 1 more entities View on Dashboard

Relationships

Strides Pharma Science===Strides Pharma International AG related ↔ Strides Pharma Science

Aditya Kumar related ↔ Strides Pharma Science

Strides Pharma Science related ↔ Sandoz

Sandoz related ↔ Strides Pharma Science===Strides Pharma International AG

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard